Journal article
Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphisms
Xenobiotica, Vol.47(1), pp.1-10
01/02/2017
Handle:
https://hdl.handle.net/2376/112556
PMCID: PMC5531270
PMID: 26999266
Abstract
1. Bisphenol-A is a ubiquitous environmental contaminant that is primarily metabolized by glucuronidation and associated with various human diseases including breast cancer. Here we identified UDP-glucuronosyltransferases (UGTs) and genetic polymorphisms responsible for interindividual variability in bisphenol-A glucuronidation in human liver and breast.
2. Hepatic UGTs showing the highest bisphenol-A glucuronidation activity included UGT2B15 and UGT1A9. Relative activity factor normalization indicated that UGT2B15 contributes >80% of activity at bisphenol-A concentrations under 5 μM, while UGT1A9 contributes up to 50% of activity at higher concentrations.
3. Bisphenol-A glucuronidation by liver microsomes (46 donors) ranged from 0.25 to 4.3 nmoles/min/mg protein. Two-fold higher glucuronidation (p = 0.018) was observed in UGT1A9 *22/*22 livers compared with *1/*1 and *1/*22 livers. However, no associations were observed for UGT2B15*2 or UGT1A1*28 genotypes.
4. Bisphenol-A glucuronidation by breast microsomes (15 donors) ranged from <0.2 to 56 fmoles/min/mg protein. Breast mRNA expression of UGTs capable of glucuronidating bisphenol-A was highest for UGT1A1, followed by UGT2B4, UGT1A9, UGT1A10, UGT2B7 and UGT2B15. Bisphenol-A glucuronidation was over 10-fold lower in breast tissues with the UGT1A1*28 allele compared with tissues without this allele (p = 0.006).
5. UGT2B15 and UGT1A9 contribute to glucuronidation variability in liver, while UGT1A1 is important in breast.
Metrics
8 Record Views
Details
- Title
- Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphisms
- Creators
- Christina M Street - Department of Veterinary Clinical Sciences, Pharmacogenomics Laboratory, Program in Individualized Medicine (PrIMe), College of Veterinary Medicine, Washington State UniversityZhaohui Zhu - Department of Veterinary Clinical Sciences, Pharmacogenomics Laboratory, Program in Individualized Medicine (PrIMe), College of Veterinary Medicine, Washington State UniversityMoshe Finel - Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of HelsinkiMichael H Court - Department of Veterinary Clinical Sciences, Pharmacogenomics Laboratory, Program in Individualized Medicine (PrIMe), College of Veterinary Medicine, Washington State University
- Publication Details
- Xenobiotica, Vol.47(1), pp.1-10
- Academic Unit
- Veterinary Clinical Sciences, Department of
- Publisher
- Taylor & Francis
- Identifiers
- 99900547963201842
- Language
- English
- Resource Type
- Journal article